Company
Headquarters: Puning, China
Employees: 7,786
CN¥26.55 Billion
CNY as of Jan. 1, 2026
US$3.78 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥5.28 B |
| EBITDA | CN¥500.4 M |
| Gross Profit TTM | CN¥859.9 M |
| Profit Margin | 0.32% |
| Operating Margin | 1.63% |
| Quarterly Revenue Growth | -1.20% |
Kangmei Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600518